Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation (Q43702603)

26 November 2017

title

Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation (English)

1 reference

26 November 2017

0 references

1 reference

Amal H El-Kamel

1 reference

26 November 2017

Manal M Baddour

series ordinal

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

349-356

1 reference

In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Two-month ciprofloxacin implants for multibacterial bone infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Ciprofloxacin implants for bone infection. In vitro-in vivo characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

An implantable dosage form for the treatment of bone infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Characterization of crosslinked high amylose starch matrix implants. 1. In vitro release of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Antimicrobial treatment of lower respiratory tract infections in the hospital setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

On the importance and mechanisms of burst release in matrix-controlled drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Appropriate antibiotic treatment of genitourinary infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Gatifloxacin efficacy in treatment of experimental methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540601098716

10.1080/10717540601098716

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference